ReviewEuropean respiratory review : an official journal of the European Respiratory Society2017
Pulmonary vascular and cardiac impairment in interstitial lung disease.
Review in European respiratory review : an official journal of the European Respiratory Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06141603 (Comparison of Upper and Lower Limb Maximal Exercise Capacities, Muscle Oxygenation and Energy Consumption During Tests in Patients With Interstitial Lung Disease), which is not on this map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparison of Upper and Lower Limb Maximal Exercise Capacities, Muscle Oxygenation and Energy Consumption During Tests in Patients With Interstitial Lung Disease
Who cites it
22 citing papers in PubMed, 57 citations in OpenAlex.
- Pulmonary Hypertension in Patients with Moderate to Severe Hypersensitivity Pneumonitis.Respiration; international review of thoracic diseases · 2026Article
- Comorbidities' Effect on IPF: Pathogenesis and Management.Biomedicines · 2025Review
- The global burden of heart failure attributable to interstitial lung diseases: insights from the global burden of disease study 2021.BMC cardiovascular disorders · 2025Article
- Analysis of clinical features and risk factors of pulmonary hypertension associated with interstitial lung disease.Biomedical reports · 2025Article
- Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis.Pulmonary circulation · 2024Article
- Clinical implication of electrocardiogram change in patients experiencing lung transplantation with end stage lung disease.Frontiers in physiology · 2024Article
- Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DRespiratory care · 2023Article
- Review
- Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis.Life (Basel, Switzerland) · 2023Article
- Evaluating bronchial anastomotic stenosis dynamically by electrical impedance tomography in a lung transplant recipient: a case report.Annals of translational medicine · 2023Article
- The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD.Advances in therapy · 2022Review
- Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency.European respiratory review : an official journal of the European Respiratory Society · 2021Review
- Lung function and cardiovascular disease: A link.Trends in cardiovascular medicine · 2021Review
- Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.Frontiers in rehabilitation sciences · 2021Review
- Development and evaluation of an artificial intelligence system for COVID-19 diagnosis.Nature communications · 2020Article
- Airway-centered Interstitial Fibrosis Involving Smooth Muscle Hyperplasia with Severe Pulmonary Hypertension.Internal medicine (Tokyo, Japan) · 2020Article
- Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.Chest · 2020Article
- Airway-artery quantitative assessment on chest computed tomography in paediatric primary ciliary dyskinesia.ERJ open research · 2020Article
- Cardiopulmonary Exercise Testing in Patients With Interstitial Lung Disease.Frontiers in physiology · 2020Review
- Developmental Origins of Chronic Lung Diseases. Mechanical Stretch, Micro-RNAs, and Hydrogels.American journal of respiratory cell and molecular biology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.